Hottest Stories: Bluelinx Holdings Inc., Applied Genetic Technologies Corporation (NASDAQ:AGTC), A-Mark Precious Metals (NASDAQ:AMRK), Bon-Ton Stores (NASDAQ:BONT)

Posted by on Dec 17, 2015

ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) shares moved up 1.69% in last trading session and ended the day at $0.36. IMUC has a return on assets of -32.00%. ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) quarterly performance is -14.09%.

On 14 December, ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) announced the establishment of an agreement with a major Canadian cancer cooperative group, The Canadian Brain Tumour Consortium (CBTC), for the phase 3 registrational trial of its cancer immunotherapy ICT-107 in patients with newly diagnosed glioblastoma. Established in 1998, and including a national investigator network of over 100 brain tumor specialists and researchers, the CBTC partners with industry to evaluate and execute clinical trials of promising new agents in a timely and cost-effective manner. The CBTC’s major goals are furthering brain tumor research and development and supporting patients and their families who are affected by glioblastoma.

Bluelinx Holdings Inc. (NYSE:BXC) ended the last trading day at $0.59. Company weekly volatility is calculated as 14.07% and price to cash ratio as 7.65. Bluelinx Holdings Inc. (NYSE:BXC) showed a weekly performance of 7.27%.

On 14 December, BlueLinx Holdings Inc. (NYSE:BXC) announced that the Company’s Board of Directors has approved a 1-for-10 reverse stock split of the Company’s common stock, and plans to seek stockholder approval of the reverse stock split at its 2016 annual stockholders’ meeting in an effort to meet the minimum per share market price requirements for continued listing on the New York Stock Exchange. The time, date, location, and other details regarding the annual stockholders’ meeting will be communicated to stockholders at a later date in the Company’s annual proxy materials.

On 16 December, Applied Genetic Technologies Corporation (NASDAQ:AGTC) shares moved up 3.96% and was closed at $17.86. Applied Genetic Technologies Corporation (NASDAQ:AGTC) year to date (YTD) performance is -15.03%.

Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, announced that the company has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ:NBI), effective December 21, 2015.

A-Mark Precious Metals, Inc. (NASDAQ:AMRK) shares moved up 6.43% in last trading session and ended the day at $17.70. AMRK Gross Margin is 0.50% and its has a return on assets of 3.20%. A-Mark Precious Metals, Inc. (NASDAQ:AMRK) quarterly performance is 55.10%.

A-Mark Precious Metals (NASDAQ:AMRK) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research note issued on Tuesday, MarketBeat Ratings reports. The brokerage presently has a $18.00 price target on the stock. Zacks Investment Research‘s target price points to a potential upside of 14.94% from the stock’s previous close.

Bon-Ton Stores Inc. (NASDAQ:BONT) caters to the Services space. It has a net profit margin of -1.30% and weekly performance is 0.52%. On the last day of trading company shares ended up at $1.94. Bon-Ton Stores Inc. (NASDAQ:BONT) distance from 50-day simple moving average (SMA50) is -4.23%.

The Bon-Ton Stores, Inc. (NASDAQ:BONT), has announced it will host Santa Fest in all of its 252 Bon-Ton department stores on Saturday, December 5 for Santa Fest, a one day shopping event where children can get their photos taken with Santa*, enter for a chance to win prizes including $25 gift cards and one giant three-foot tall teddy bear. Everyone can enjoy free Ghirardelli candy giveaways, candy canes and Keurig brewed hot chocolate while participating in fun activities.

Leave a Reply

Your email address will not be published. Required fields are marked *